First Manhattan CO Regenxbio Inc. Transaction History

First Manhattan CO

$29.6 Billion
Q1 2024

A detailed history of First Manhattan CO transactions in Regenxbio Inc. stock. As of the latest transaction made, First Manhattan CO holds 10,600 shares of RGNX stock, worth $112,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,600

Previous 10,600 -0.0%

Holding current value

$112,678

Previous $190,000 17.37%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.89 - $20.82 $7.39 Million - $11.9 Million	-573,030 Reduced 98.18%	10,600 $190,000
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $567,870 - $689,655	34,500 Added 6.28%	583,630 $9.61 Million
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $1.75 Million - $2.2 Million	101,400 Added 22.65%	549,130 $11 Million
Q1 2023 May 15, 2023	BUY	$18.08 - $24.55 $191,647 - $260,230	10,600 Added 2.42%	447,730 $8.47 Million
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $5.48 Million - $6.64 Million	-268,600 Reduced 38.06%	437,130 $9.91 Million

Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $181,212 - $328,149	9,365 Added 1.34%	705,730 $17.4 Million
Q1 2022 May 16, 2022	BUY	$24.62 - $34.31 $2.59 Million - $3.61 Million	105,305 Added 17.82%	696,365 $23.1 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $688,090 - $918,061	22,792 Added 4.01%	591,060 $19.3 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $5.08 Million - $7.98 Million	174,700 Added 44.39%	568,268 $23.8 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $1.95 Million - $2.44 Million	60,178 Added 18.05%	393,568 $15.3 Million
Q1 2021 May 14, 2021	SELL	$33.61 - $49.95 $867,138 - $1.29 Million	-25,800 Reduced 7.18%	333,390 $11.4 Million
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $6.89 Million - $12.8 Million	259,847 Added 261.57%	359,190 $16.3 Million
Q3 2020 Nov 12, 2020	BUY	$27.01 - $40.26 $346,673 - $516,737	12,835 Added 14.84%	99,343 $2.73 Million
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $47,175 - $73,848	-1,700 Reduced 1.93%	86,508 $3.19 Million
Q1 2020 May 06, 2020	BUY	$21.5 - $54.2 $1.9 Million - $4.78 Million	88,208 New	88,208 $2.86 Million

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $460M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Regenxbio Inc. Transaction History